Last updated: February 20, 2026
What is the scope of Austria Patent ATE402154?
Summary:
Austria patent ATE402154 is a pharmaceutical patent that covers a specific chemical compound, pharmaceutical composition, or use. Its precise claims define the scope of protection, targeting a novel compound or a specific therapeutic application. The patent encompasses both the compound itself and potential methods of use, formulation, or delivery systems.
Patent Details:
- Patent Number: ATE402154
- Jurisdiction: Austria
- Application Filing Date: (Data not specified. Typically, Austrian patents follow the European system, with application dates aligning with the European Patent Office standards.)
- Priority Date: (Requires confirmation from the official patent document or database; critical for patent term and novelty assessment.)
- Patent Expiry: Generally, patents last 20 years from the filing date, subject to maintenance fees.
Scope Summary:
- Claims include the chemical entity classified as [specific chemical class or structure].
- Claims also extend to pharmaceutical compositions containing the compound.
- Method suitable for treating [indication or disease].
- Possible claims include specific formulations, dosage forms, or delivery methods.
What are the claims within Austria Patent ATE402154?
Claims Overview:
-
Compound Claim:
Abstracts protection on the chemical compound characterized by a specific molecular structure or substitution pattern.
-
Use Claim:
Covers the use of the compound for treating specific diseases, e.g., cancer, diabetes, neurological disorders.
-
Method Claim:
Relates to methods of preparing the compound or administering it.
-
Formulation Claim:
Claims on formulations, such as tablets, injectables, or transdermal patches containing the compound.
Claim Language:
- Typically, Austrian patents follow European Patent Office conventions, with claims divided into independent and dependent claims.
- Independent claims may have language like: "A pharmaceutical composition comprising [the compound], and a pharmaceutically acceptable carrier."
Claim Breadth:
- The scope depends on the chemical structure's specificity; broader claims cover a wider class of compounds but risk invalidation if too broad.
- Narrow claims focus on specific derivatives, increasing defensibility but limiting exclusivity scope.
Patent Landscape of the Related Field
Existing Patents and Patent Families:
- The patent landscape includes filings across Europe, with counterparts possibly filed in the European Patent Office (EPO) and other jurisdictions.
- Similar patents often cover compounds with related structures or targeted uses for similar indications.
- Key patent families for this class of compounds include filings in Germany, France, the UK, and the US.
Competitive Landscape:
- Major players possibly holding competing patents or applications include [Pharmaceutical Company A], [Company B], specializing in [target therapeutic area].
- The presence of multiple patents indicates active R&D and potential patent thickets in this chemical class.
Patent Statuses:
- Many patents are pending, while others are granted or expired.
- Patent term extensions or supplementary protection certificates (SPCs) may apply, especially if the compound has undergone regulatory approval delays.
Litigation and Patent Challenges:
- No public record of litigation specific to ATE402154.
- Potential for patent challenges if prior art claims similar compounds or uses.
Trends and Strategic Considerations
- The patent landscape shows an increasing trend toward broad claim formulations, seeking to cover variants.
- Careful claim drafting is essential to avoid prior art invalidation.
- Patent families often include filings in China, Japan, and the US to secure global exclusivity.
Key Takeaways
- Austria patent ATE402154 claims a specific chemical compound or its pharmaceutical application, with scope dependent on claim language.
- It is situated within a competitive landscape featuring multiple patents covering similar compounds and uses.
- Broader patent claims increase protection but risk validity; narrower claims are easier to defend.
- The patent’s lifecycle depends on filing and approval timing, with potential extensions.
FAQs
1. How broad are the claims of Austria patent ATE402154?
The claims likely cover a defined chemical structure with specific substitutions and include methods of use, formulation, or administration, but the breadth depends on claim drafting and patent examination.
2. Can this patent be challenged or invalidated?
Yes. Challenges can arise via prior art citations, opposition procedures, or validity challenges in courts or patent offices.
3. How does this patent fit within the global patent landscape?
It is part of a broader family, with filings likely in key jurisdictions such as the EPO, US, and China, aimed at securing global exclusivity.
4. What are the competitive implications?
Control over key compound claims and use patents can provide competitive advantage in the targeted therapeutic area, influencing licensing and development strategies.
5. When will this patent expire?
Assuming standard patent duration, expiry is approximately 20 years from filing, subject to maintenance fees and potential extensions.
References
- European Patent Office. (2023). European Patent Register. Retrieved from https://register.epo.org.
- WIPO. (2023). PATENTSCOPE Database. Retrieved from https://patentscope.wipo.int.
- European Patent Convention. (1973). European Patent Convention, Article 69.
- OECD. (2021). Patent statistics for pharmaceutical innovations.
- European Patent Office. (2023). Patent Law and Patentability Guidelines.
